ripretinib
Showing 1 - 16 of 16
Ripretinib in Chinese Advanced GIST: a Real World Study
Active, not recruiting
- Gastrointestinal Stromal Tumors
- Ripretinib Oral Tablet
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jan 15, 2023
Gastrointestinal Stromal Tumors Trial (Ripretinib, binimetinib)
Withdrawn
- Gastrointestinal Stromal Tumors
- Ripretinib
- binimetinib
- (no location specified)
Dec 15, 2021
GIST - Gastrointestinal Stromal Tumor Trial in Jacksonville, Miami, Portland (Ripretinib, Repaglinide)
Recruiting
- GIST - Gastrointestinal Stromal Tumor
- Ripretinib
- Repaglinide
-
Jacksonville, Florida
- +2 more
Mar 7, 2022
Ripretinib Combined With Surgery in Advanced GIST That Have
Recruiting
- Gastrointestinal Stromal Tumor(GIST)
- Resection surgery of gastrointestinal stromal tumor
-
Chengdu, Sichuan, ChinaSichuan Provincial People's Hospital
Apr 25, 2022
Gastrointestinal Stromal Tumors Trial in Shanghai (Ripretinib treatment)
Recruiting
- Gastrointestinal Stromal Tumors
- Ripretinib treatment
-
Shanghai, Shanghai, ChinaRenji Hospital Affiliated to Shanghai Jiaotong University School
Nov 12, 2021
Gastrointestinal Stromal Tumors Trial in Worldwide (DCC-2618, Placebo Oral Tablet)
Completed
- Gastrointestinal Stromal Tumors
- DCC-2618
- Placebo Oral Tablet
-
Scottsdale, Arizona
- +34 more
Nov 17, 2022
GIST - Gastrointestinal Stromal Tumor Trial (ripretinib)
Approved for marketing
- GIST - Gastrointestinal Stromal Tumor
- ripretinib
- (no location specified)
May 27, 2020
Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers Trial in Worldwide (DCC-2618)
Active, not recruiting
- Gastrointestinal Stromal Tumors
- +2 more
-
Scottsdale, Arizona
- +25 more
Apr 16, 2021
Gastrointestinal Stromal Tumor(GIST) Trial in China (Ripretinib, Sunitinib)
Recruiting
- Gastrointestinal Stromal Tumor(GIST)
- Ripretinib
- Sunitinib
-
Beijing, Beijing, China
- +17 more
Dec 17, 2020
Gastrointestinal Stromal Tumors Trial in Seoul (Rivoceranib Mesylate, Paclitaxel)
Not yet recruiting
- Gastrointestinal Stromal Tumors
- Rivoceranib Mesylate, Paclitaxel
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jun 7, 2023
Gastrointestinal Stromal Tumor (GIST), Digestive System Disease, Gastrointestinal Diseases Trial in Boston (IDRX-42)
Recruiting
- Gastrointestinal Stromal Tumor (GIST)
- +3 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Aug 16, 2022
Second-line Pharmacotherapy Patterns and Outcomes of Advanced
Not yet recruiting
- Gastrointestinal Stromal Tumors
-
Guangzhou, Guangdong, ChinaThe first affiliated hospital,Sun yat-sen university
Jun 30, 2022